Pre-eclampsia and magnesium toxicity with therapeutic plasma level in a woman with m.3243A>G melas mutation.
Moriarty
K T
KT
Queen Elizabeth Hospital, Woolwich, London. estherandtim@btinternet.com
McFarland
R
R
Whittaker
R
R
Burch
J
J
Turnbull
H E
HE
Taylor
R W
RW
Turnbull
D M
DM
D000328:Adult; D002585:Cesarean Section; D004272:DNA, Mitochondrial / Q000235:genetics*; D005260:Female; D005500:Follow-Up Studies; D005820:Genetic Testing; D005865:Gestational Age; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D017241:MELAS Syndrome / Q000150:complications / Q000175:diagnosis / Q000235:genetics*; D008278:Magnesium Sulfate / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood; D008297:Male; D017354:Point Mutation; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery; D011247:Pregnancy; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D018570:Risk Assessment
D004272:DNA, Mitochondrial; D008278:Magnesium Sulfate